Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Clinical trial NCT00036556 · COMPLETED

Trial details

NCT number: NCT00036556
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2001-06-01
Enrollment: 941

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.